Al's Comment:

 This is a very interesting drug. It is a smart bomb. It seeks out IL13Ra2 which is a cell surface protein present on many types of cancer cells (including Glioblastomas, and DIPG), and rarely found on normal cells. It carries along a pseudomonas exotoxin that kills the cells that the drug attaches to. The net effect is that it kills tumor cells without harming the normal cells.  The Musella Foundation has given a few grants to support the creation of this drug over the last 11 years and I am so happy to see it has received orphan designation. That will make it easier and cheaper to  bring it to patients.


Posted on: 01/23/2021

Targepeutics Receives Orphan Drug Designation for Lead Drug Targeting Malignant Glioma

 


Click HERE to return to brain tumor news headlines.